Monte Rosa Therapeutics, Inc.
GLUE
Revenue
0.00
0.000.00%
-Assets
344.11M
▲77.37M▲29.00%
3 Months ChangeLiabilities
119.44M
▲5.22M▲4.57%
3 Months ChangeFree Cash Flow
-39.55M
▼-6.96M▼-21.36%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0000950170-24-117567
2024-08-08
Form 10-Q
ID: 0000950170-24-093296
2024-08-08
Form 8-K
ID: 0000950170-24-093294
2024-06-27
Form 8-K
ID: 0000950170-24-078159
2024-06-12
Form 8-K
ID: 0000950170-24-072407
2024-05-30
Form 8-K
ID: 0001193125-24-149802
2024-05-16
Form 8-K
ID: 0001193125-24-140533
2024-05-09
Form 10-Q
ID: 0000950170-24-056288
2024-05-09
Form 8-K
ID: 0000950170-24-056253
2024-05-02
Form 8-K
ID: 0000950170-24-052055